53.24
0.74 (1.42%)
| Penutupan Terdahulu | 52.49 |
| Buka | 52.85 |
| Jumlah Dagangan | 522,983 |
| Purata Dagangan (3B) | 1,034,127 |
| Modal Pasaran | 2,922,164,992 |
| Harga / Jualan (P/S) | 7.74 |
| Harga / Buku (P/B) | 5.67 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 25 Feb 2025 |
| Margin Keuntungan | -36.20% |
| Margin Operasi (TTM) | -39.67% |
| EPS Cair (TTM) | -1.69 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 55.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 21.02% |
| Nisbah Semasa (MRQ) | 8.95 |
| Aliran Tunai Operasi (OCF TTM) | -83.91 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -58.77 M |
| Pulangan Atas Aset (ROA TTM) | -13.36% |
| Pulangan Atas Ekuiti (ROE TTM) | -27.62% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Menurun | Menurun |
| Medical Devices (Global) | Menurun | Menurun | |
| Stok | PROCEPT BioRobotics Corporation | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | 1.5 |
| Volatiliti Harga | 4.5 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -2.5 |
| Purata | 0.40 |
|
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 4.22% |
| % Dimiliki oleh Institusi | 93.06% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 68.00 (Morgan Stanley, 27.74%) | Beli |
| Median | 58.00 (8.95%) | |
| Rendah | 55.00 (Piper Sandler, 3.32%) | Beli |
| Purata | 60.33 (13.33%) | |
| Jumlah | 3 Beli | |
| Harga Purata @ Panggilan | 45.73 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Piper Sandler | 07 Aug 2025 | 55.00 (3.32%) | Beli | 39.59 |
| Wells Fargo | 07 Aug 2025 | 58.00 (8.95%) | Beli | 39.59 |
| Morgan Stanley | 15 Jul 2025 | 68.00 (27.74%) | Beli | 58.01 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| DESAI ANTAL ROHIT | - | - | 0 | 0 |
| MOLL FREDERIC H | 40.38 | - | 20,000 | 807,600 |
| NOURI ALALEH | - | - | 0 | 0 |
| Jumlah Keseluruhan Kuantiti Bersih | 20,000 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 807,600 | |||
| Purata Pembelian Keseluruhan ($) | 40.38 | |||
| Purata Jualan Keseluruhan ($) | - | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| NOURI ALALEH | Pegawai | 14 Aug 2025 | Pelaksanaan pilihan | 11,000 | - | - |
| DESAI ANTAL ROHIT | Pengarah | 14 Aug 2025 | Pelaksanaan pilihan | 26,749 | - | - |
| MOLL FREDERIC H | Pengarah | 13 Aug 2025 | Beli (+) | 20,000 | 40.38 | 807,600 |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 06 Aug 2025 | Pengumuman | PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance |
| 24 Jul 2025 | Pengumuman | PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO |
| 23 Jul 2025 | Pengumuman | Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy |
| 21 Jul 2025 | Pengumuman | PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025 |
| 14 Jul 2025 | Pengumuman | Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |